MMCAP International’s Orion Biotech Opportunities Corp. Warrant ORIAW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-159,802
Closed -$12.8K – 264
2023
Q1
$12.8K Hold
159,802
– – ﹤0.01% 214
2022
Q4
$24.2K Hold
159,802
– – ﹤0.01% 260
2022
Q3
$20K Hold
159,802
– – ﹤0.01% 371
2022
Q2
$24K Hold
159,802
– – ﹤0.01% 393
2022
Q1
$59K Sell
159,802
-198
-0.1% -$102 ﹤0.01% 418
2021
Q4
$154K Hold
160,000
– – 0.01% 360
2021
Q3
$139K Buy
+160,000
New +$208K 0.01% 345

MMCAP International's ORIAW Position: Q2 2023 in Review

MMCAP International sold out of Orion Biotech Opportunities Corp. Warrant (ORIAW) in Q2 2023, closing a stake of 159,802 shares — an estimated $12.8K sold.

MMCAP International first reported a position in ORIAW in Q3 2021 and held it in 7 quarters. The position peaked at $154K in Q4 2021. 0 funds tracked by Wall St. Rank hold ORIAW as of Q2 2023.

  • MMCAP International reported no remaining Orion Biotech Opportunities Corp. Warrant position as of Q2 2023 after selling out during the quarter.
  • MMCAP International sold 159,802 Orion Biotech Opportunities Corp. Warrant shares in Q2 2023, an estimated $12.8K.
  • MMCAP International first reported a position in Orion Biotech Opportunities Corp. Warrant in Q3 2021 and held it in 7 quarters.
  • MMCAP International's Orion Biotech Opportunities Corp. Warrant position peaked at $154K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Warrant as of Q2 2023.

Based on MMCAP International's 13F filing for Q2 2023, filed 14 Aug 2023.